1. Home
  2. Browse Decisions
  3. IN RE SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE) ANTITRUST LITIGATION
 

IN RE SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE) ANTITRUST LITIGATION

No. 13-MD-2445, Civ. A. No. 16-5073.

IN RE SUBOXONE (BUPRENORPHINE HYDROCHLORIDE AND NALOXONE) ANTITRUST LITIGATION. THIS DOCUMENT RELATES TO: Wisconsin, et al. v. Indivior Inc. et al. Case No. 16-cv-5073. STATE OF WISCONSIN By Attorney General Brad D. Schimel, et al. Plaintiffs, v. INDIVIOR INC. f/k/a RECKITT BENCKISER PHARMACEUTICALS, INC., et al. Defendants.

United States District Court, E.D. Pennsylvania.

September 8, 2017.

Editors Note
Applicable Law: 15 U.S.C. § 1
Cause: 15 U.S.C. § 1 Antitrust Litigation
Nature of Suit: 410 Other Statutes: Anti-Trust
Source: PACER

MEMORANDUM OPINION

In this next installment of the ongoing antitrust litigation regarding the prescription drug Suboxone, a collection of states1 (collectively, "Plaintiffs" or the "States"), have brought suit against Defendants Indivior Inc., f/k...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases